Literature DB >> 19703834

Impact of renal function on coronary plaque composition.

Motohiro Miyagi1, Hideki Ishii, Ryuichiro Murakami, Satoshi Isobe, Mutsuharu Hayashi, Tetsuya Amano, Kosuke Arai, Daiji Yoshikawa, Taiki Ohashi, Tadayuki Uetani, Yoshinari Yasuda, Seiichi Matsuo, Tatsuaki Matsubara, Toyoaki Murohara.   

Abstract

BACKGROUND: Recent studies have demonstrated that patients with chronic kidney disease are at high risk of atherosclerosis. Recently it has been found that coronary plaque components can be evaluated by integrated backscatter intravascular ultrasound (IB-IVUS), and lipid-rich plaque is associated with vulnerable plaque. The aim of the study was to investigate the relationship between renal function and tissue characterization of coronary plaque composition at the target stenotic site for percutaneous coronary intervention (PCI).
METHODS: We prospectively performed IB-IVUS before elective PCI in 89 consecutive patients with stable angina. According to estimated glomerular filtration rate (eGFR), they were divided into two groups (eGFR <60 ml/min/ 1.73 m(2) or eGFR > or =60 ml/min/1.73 m(2)). The tissue characteristics of the coronary plaque at each target stenotic site were evaluated by three-dimensional (3D) IB-IVUS just before PCI procedure.
RESULTS: The patients with eGFR <60 ml/min/1.73 m(2) had higher percentage of lipid volume and lower percentage of fibrous volume compared to the patients with eGFR > or = 60 ml/min/1.73 m(2) on the 3D IB-IVUS images (36.7 +/- 10.6% versus 28.7 +/- 9.3%, P < 0.001 and 59.1 +/- 8.7% versus 66.3 +/- 8.3%, P < 0.001, respectively). eGFR showed a significant negative correlation with lipid volume and had a significant positive correlation with fibrous volume in coronary plaques (r = -0.44, P < 0.0001, and r = 0.46, P < 0.0001, respectively).
CONCLUSIONS: Impaired renal function was related to higher percentage of lipid volume and lower percentage of fibrous volume in coronary plaque. Our findings may explain the increasing risk of cardiovascular events in patients with renal dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19703834     DOI: 10.1093/ndt/gfp423

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients.

Authors:  Yusuke Izumi; Mutsuharu Hayashi; Ryota Morimoto; Xian Wu Cheng; Hongxian Wu; Hideki Ishii; Yoshinari Yasuda; Daiji Yoshikawa; Hideo Izawa; Seiichi Matsuo; Yutaka Oiso; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

2.  Possible Inhibitory Effect of Erythropoiesis-Stimulating Agents at the Predialysis Stage on Early-Phase Coronary Events after Hemodialysis Initiation.

Authors:  Masato Nishimura; Keitaro Watanabe; Yuki Kitamura; Takao Nagashima; Toshiko Tokoro; Toru Takatani; Nodoka Sato; Satoru Yamazaki; Tetsuya Hashimoto; Hiroyuki Kobayashi; Toshihiko Ono
Journal:  Cardiorenal Med       Date:  2016-08-12       Impact factor: 2.041

Review 3.  Atherosclerosis in chronic kidney disease: the role of macrophages.

Authors:  Valentina Kon; MacRae F Linton; Sergio Fazio
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

Review 4.  Imaging of coronary atherosclerosis in various susceptible groups.

Authors:  Ravi Kiran Munnur; Nitesh Nerlekar; Dennis T L Wong
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

5.  Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.

Authors:  Kazuhiro Dan; Toru Miyoshi; Makoto Nakahama; Tomofumi Mizuno; Kenzo Kagawa; Yoichiro Naito; Satoshi Kawada; Hiroshi Ito
Journal:  Cardiorenal Med       Date:  2018-03-27       Impact factor: 2.041

6.  Prognostic impact of lipid contents on the target lesion in patients with drug eluting stent implantation.

Authors:  Soichiro Kumagai; Hiroaki Takashima; Katsuhisa Waseda; Hirohiko Ando; Akihiro Suzuki; Tadayuki Uetani; Ken Harada; Tomohiro Yoshida; Ayako Kunimura; Yusaku Shimbo; Katsuhide Kitagawa; Kazuhiro Harada; Hideki Ishii; Daiji Yoshikawa; Tatsuaki Matsubara; Toyoaki Murohara; Tetsuya Amano
Journal:  Heart Vessels       Date:  2013-10-20       Impact factor: 2.037

7.  Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.

Authors:  Kuninobu Kashiyama; Shinjo Sonoda; Yoshitaka Muraoka; Yoshiyuki Suzuki; Fumihiko Kamezaki; Yuki Tsuda; Masaru Araki; Masahito Tamura; Masaaki Takeuchi; Haruhiko Abe; Masahiro Okazaki; Yoshihisa Fujino; Yutaka Otsuji
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-28       Impact factor: 2.357

8.  Clinical Predictors for Lack of Favorable Vascular Response to Statin Therapy in Patients With Coronary Artery Disease: A Serial Optical Coherence Tomography Study.

Authors:  Yoshiyasu Minami; Zhao Wang; Aaron D Aguirre; Daniel S Ong; Chong-Jin Kim; Shiro Uemura; Tsunenari Soeda; Hang Lee; James Fujimoto; Ik-Kyung Jang
Journal:  J Am Heart Assoc       Date:  2017-11-01       Impact factor: 5.501

9.  Morphologic characterization and quantification of superficial calcifications of the coronary artery--in vivo assessment using optical coherence tomography.

Authors:  Masaya Matsumoto; Daiji Yoshikawa; Hideki Ishii; Seiichi Hayakawa; Miho Tanaka; Soichiro Kumagai; Mutsuharu Hayashi; Toyoaki Murohara
Journal:  Nagoya J Med Sci       Date:  2012-08       Impact factor: 1.131

10.  Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus.

Authors:  Kentaro Kakuta; Kaoru Dohi; Miho Miyoshi; Takashi Yamanaka; Masaki Kawamura; Jun Masuda; Tairo Kurita; Toru Ogura; Norikazu Yamada; Yasuhiro Sumida; Masaaki Ito
Journal:  Cardiovasc Diabetol       Date:  2017-10-12       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.